Research & development

Infant Bacterial Therapeutics' most advanced clinical program is the IBP-9414 project developing a preventive treatment against necrotizing enterocolitis (NEC).
Read more

Calendar

September 6, 2018
Pareto Securities Health Care Conference, Stockholm

November 14, 2018
Interim report January-September 2018

November 27, 2018
Nordea Tech & Medtech Seminar, Stockholm

November 29, 2018
Nordic-American Life Science Conference, New York
Read More